Terpenes are produced in the trichomes of the cannabis leaves, where THC is created, and are common constituents of the plant’s distinctive flavor and aroma. Terpenes also act as essential, medicinal hydrocarbon building blocks, influencing the overall homeopathic and therapeutic effect of the product. The characterization of terpenes and their synergistic effect with cannabinoids is key for identifying the correct cannabis treatment plan for patients with pain, anxiety, epilepsy, depression, cancer and other illnesses.
This test is not required by most states but it is recommended.
The instrumentation that is used for analyzing terpene profiles is a GCMS with a headspace autosampler – which has already been discussed for residual solvents testing. Since residual solvents testing is a required analysis by most states, all of the instrumentation required for terpene profiling will already be in your lab.
Cannalytics uses the Shimadzu GCMS-QP2020
with headspace sampler, Residual Solvents Testing
Cannalytics does not support or promote the use of its products or services in connection with illegal use, cultivation or trade of cannabis products. Cannalytics products and services are intended to be used for research purposes only or state-approved medical research. Testing regulations and requirements vary by state, current cannabis testing regulations and requirements are strictly adhered too no exceptions.
Copyright © 2018 Cannalytics Research Center - All Rights Reserved.